Pharmaceuticals, Biotechnology and Life Sciences
LA ROCHELLE, France–(BUSINESS WIRE)–Regulatory News: VALBIOTIS (FR0013254851 – ALVAL / eligible for the PEA/SME) (Paris:ALVAL), a French Research & Development…
Atara achieved significant progress across its three strategic priorities in 2020 Atara is well-positioned for success in anticipated tab-cel® regulatory…
– Cabozantinib Franchise Preliminary Net Product Revenue of $200 million for the Fourth Quarter 2020, and $741 million for the…
BURLINGAME, Calif. & CHICAGO–(BUSINESS WIRE)–Humanigen, Inc. (HGEN) (Humanigen), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response…
BURLINGAME, Calif. & CHICAGO–(BUSINESS WIRE)–Humanigen, Inc. (HGEN) (Humanigen), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response…
LAKE ZURICH, Ill.–(BUSINESS WIRE)–Fresenius Kabi USA is voluntarily recalling a single lot of Ketorolac Tromethamine Injection, USP, 30 mg/mL, 1…
TEL AVIV, Israel–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release…
– Early and Cost-Effective Identification of Samples Potentially Containing the B.1.1.7 or Other Variants May Help Reduce Further Spread of…
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–#cureduchenne–CureDuchenne, a leading global nonprofit dedicated to finding and funding a cure for Duchenne muscular dystrophy (DMD),…
DUBLIN–(BUSINESS WIRE)–The “Contract Research Organizations (CRO) Market by Services (Clinical Research [Phase II, Phase III], Pre-Clinical [Pharmacokinetics, Toxicology], Laboratory Services,…